Clinical Trials Browser

Phase 1 × Glioblastoma × niraparib × Clear all

NCT05666349 2024-03-26

RiNG

Phase 1 Withdrawn

Glioblastoma

NCT01294735 2012-08-15

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Phase 1 Completed

CNSDermatologic

Glioblastoma, Melanoma